Findings from clinical and research studies suggest that the overall health-related quality of life of many colorectal cancer survivors is good. However, many survivors report significant sexual dysfunction after treatment that may adversely affect their quality of life in survivorship.
Methods:
This article examines studies investigating sexual function in men and women treated for colorectal cancer. Also included are data on the prevalence and nature of sexual dysfunctions in colorectal cancer survivors, the impact of specific treatment modalities for colorectal cancer on sexual function, and the management of sexual dysfunction in men and women.
Results:
Published studies investigating sexual dysfunction after colorectal cancer treatment generally have been limited conceptually and methodologically. However, findings suggest that the prevalence of sexual dysfunction among colorectal cancer survivors is high.
Conclusions:
Sexual dysfunction is often a long-term and late effect of treatment for colorectal cancer. The assessment and management of sexual dysfunction in men and women treated for colorectal cancer should be standard practice throughout treatment and in survivorship.
HewittM., GreenfieldS., StovallE., eds. From Cancer Patient to Cancer Survivor: Lost in Transition.Committee on Cancer Survivorship: Improving Care and Quality of Life, Institute of Medicine and National Research Council. Washington, DC: The National Academies Press;2005.
5.
ArndtV., MerxH., StegmaierC.. Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study.J Clin Oncol.2004; 22(23): 4829–4836.
6.
RauchP., MinyJ., ConroyT.. Quality of life among disease-free survivors of rectal cancer.J Clin Oncol.2004; 22(2): 354–360.
7.
RamseyS.D., AndersenM.R., EtzioniR.. Quality of life in survivors of colorectal carcinoma.Cancer.2000; 88(6): 1294–1303.
8.
DunnJ., LynchB., RinaldisM.. Dimensions of quality of life and psychosocial variables most salient to colorectal cancer patients.Psy-chooncology.2006; 15(1): 20–30.
9.
Camilleri-BrennanJ., SteeleR.J.. Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer.Br J Surg.2001; 88(12): 1617–1622.
10.
ArndtV., MerxH., StegmaierC.. Restrictions in quality of life in colorectal cancer patients over three years after diagnosis: a population based study.Eur J Cancer.2006; 42(12): 1848–1857.
11.
MarijnenC.A., van de VeldeC.J., PutterH.. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial.J Clin Oncol.2005; 23(9): 1847–1858.
12.
HavengaK., MaasC.P., DeRuiterM.C.. Avoiding long-term disturbance to bladder and sexual function in pelvic surgery, particularly with rectal cancer.Sem Surg Oncol.2000; 18(3): 235–243.
13.
HendrenS.K., O'ConnorB.I., LiuM.. Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer.Ann Surg.2005; 242(2): 212–223.
14.
SiderisL., ZenasniF., VernereyD.. Quality of life of patients operated on for low rectal cancer: impact of the type of surgery and patients’ characteristics.Dis Colon Rectum.2005; 48(12): 2180–2191.
15.
GurenM.G., EriksenM.T., WiigJ.N.. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer.Eur J Surg Oncol.2005; 31(7): 735–742.
16.
BreukinkS.O., van DrielM.F., PierieJPEN,. Male sexual function and lower urinary tract symptoms after laparoscopic total mesorectal excision.Int J Colorectal Dis.2008; 23(12): 1199–1205.
17.
QuahH.M., JayneD.G., EuK.W.. Bladder and sexual dysfunction follow laparoscopically assisted and conventional open mesorectal resection for cancer.Br J Surg.2002; 89(12): 1551–1556.
18.
PereraM.T., DeenK.I., WijesuriyaS.R.. Sexual and urinary dysfunction following rectal dissection compared with segmental colectomy.Colorectal Dis.2008; 10(7): 689–693.
19.
Di FabioF., KollerM., NascimbeniR.. Long-term outcome after colorectal cancer resection. Patients’ self-reported quality of life, sexual dysfunction and surgeons’ awareness of patients’ needs.Tumori.2008; 94(1): 30–35.
20.
NesbakkenA., NygaardK., Bull-NjaaT.. Bladder and sexual dysfunction after mesorectal excision for rectal cancer.Br J Surg.2000; 87(2): 206–210.
21.
HassanI., CimaR.R.. Quality of life after rectal resection and multimodality therapy.J Surg Oncol.2007; 96(8): 684–692.
22.
MannaertsG.H., SchijvenM.P., HendrikxA.. Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer.Eur J Surg Oncol.2001; 27(3): 265–272.
23.
SprangersM.A., te VeldeA., AaronsonN.K.. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.Eur J Cancer.1999; 35(2): 238–247.
24.
AaronsonN.K., AhmedzaiS., BergmanB.. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.J Natl Cancer Inst.1993; 85(5): 365–376.
25.
GujralS., ConroyT., FleissnerC.. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire.Eur J Cancer.2007; 43(10): 1564–1573.
26.
RosenR.C., RileyA., WagnerG.. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.Urology.1997; 49(6): 822–830.
27.
LiangJ.T., LaiH.S., LeeP.H.. Laparoscopic pelvic autonomic nerve-preserving surgery for sigmoid colon cancer.Ann Surg Oncol.2008; 15(6): 1609–1616.
28.
RosenR., BrownC., HeimanJ.The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.J Sex Marital Ther.2000; 26(2): 191–208.
29.
da SilvaG.M., HullT., RobertsP.L.. The effect of colorectal surgery in female sexual function, body image, self-esteem and general health: a prospective study.Ann Surg.2008; 248(2): 266–272.
30.
EngelJ., KerrJ., Schlesinger-RaabA.. Quality of life in rectal cancer patients: a four-year prospective study.Ann Surg.2003; 238(2): 203–213.
31.
JayneD.G., GuillouP.J., ThorpeH.. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC Trial Group.J Clin Oncol.2007; 25(21): 3061–3068.
32.
JayneD.G., BrownJ.M., ThorpeH.. Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique.Br J Surg.2005; 92(9): 1124–1132.
33.
WiegelM., MestonC., RosenR.. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores.J Sex Marital Ther.2005; 31(1): 1–20.
34.
LaumannE.O., PaikA., RosenR.C.. Sexual dysfunction in the United States: prevalence and predictors.JAMA.1999; 281(6): 537–544.
35.
DerogatisL.R., BurnettA.L.. The epidemiology of sexual dysfunctions.J Sex Med.2008; 5(2): 289–300.
36.
TempleL.K., WongW.D., MinskyB.. The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation.Semin Radiat Oncol.2003; 13(4): 469–477.
37.
SchoverL.R.. Premature ovarian failure and its consequences: vaso-motor symptoms, sexuality, and fertility.J Clin Oncol.2008; 26(5): 753–758.
38.
KeatingJ.P.. Sexual function after rectal excision.ANZ J Surg.2004; 74(4): 248–259.
39.
MoriyaY.. Function preservation in rectal cancer surgery.Int J Clin Oncol.2006; 11(5): 339–343.
40.
BöhmG., Kirschner-HermannsR., DeciusA.. Anorectal, bladder, and sexual function in females following colorectal surgery for carcinoma.Int J Colorectal Dis.2008; 23(9): 893–900.
41.
SchmidtC.E., BestmannB., KüchlerT.. Factors influencing sexual function in patients with rectal cancer.Int J Impot Res.2005; 17(3): 231–238.
42.
EnkerW.E.. Total mesorectal excision — the new golden standard of surgery for rectal cancer.Ann Med.1997; 29(2): 127–133.
43.
PocardM., ZinzindohoueF., HaabF.. A prospective study of sexual and urinary function before and after total mesorectal excision with autonomic nerve preservation for rectal cancer.Surgery.2002; 131(4): 368–372.
44.
BreukinkS.O., van der Zaag-LoonenH.J., BoumaE.M.. Prospective evaluation of quality of life and sexual functioning after laparoscopic total mesorectal excision.Dis Colon Rectum.2007; 50(2): 147–155.
45.
MorinoM., PariniU., AllaixM.E.. Male sexual and urinary function after laparoscopic total mesorectal excision.Surg Endosc.2009; 23(6): 1233–1240.
46.
MaurerC.A., Z'GraggenK., RenzulliP.. Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery.Br J Surg.2001; 88(11): 1501–1505.
47.
ZippeC., NandipatiK., AgarwalA.. Sexual dysfunction after pelvic surgery.Int J Impot Res.2006; 18(1): 1–18.
48.
CornishJ.A., TilneyH.S., HeriotA.G.. A meta-analysis of quality of life for abdominoperineal excision of rectum versus anterior resection for rectal cancer.Ann Surg Oncol.2007; 14(7): 2056–2068.
49.
SchmidtC.E., BestmannB., KüchlerT.. Prospective evaluation of quality of life of patients receiving either abdominoperineal resection or sphincter-preserving procedure for rectal cancer.Ann Surg Oncol.2005; 12(2): 117–123.
50.
VironenJ.H., KairaluomaM., AaltoA.M.. Impact of functional results on quality of life after rectal cancer surgery.Dis Colon Rectum.2006; 49(5): 568–578.
51.
BirgissonH., PåhlmanL., GunnarssonU.. Late adverse effects of radiation therapy for rectal cancer: a systematic overview.Acta Oncol.2007; 46(4): 504–516.
52.
LangeM.M., MarijnenC.A., MaasC.P.. Risk factors for sexual dysfunction after rectal cancer treatment.Eur J Cancer.2009; 45(9): 1578–1588.
53.
HeriotA.G., TekkisP.P., FazioV.W.. Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: a predictive model.Ann Surg.2005; 242(4): 502–510; discussion 510-511.
54.
BonnelC., ParcY.R., PocardM.. Effects of preoperative radiotherapy for primary resectable rectal adenocarcinoma on male sexual and urinary function.Dis Colon Rectum.2002; 45(7): 934–939.
55.
AllalA.S., BieriS., PelloniA.. Sphincter-sparing surgery after preoperative radiotherapy for low rectal cancers: feasibility, oncologic results and quality of life outcomes.Br J Cancer.2000; 82(6): 1131–1137.
56.
PucciarelliS., Del BiancoP., ToppanP.. Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery.Ann Surg Oncol.2008; 15(7): 1846–1854.
57.
BreukinkS.O., WoudaJ.C., van der Werf-ElderingM.J.. Psy-chophysiological assessment of sexual function in women after radiotherapy and total mesorectal excision for rectal cancer: a pilot study on four patients.J Sex Med.2009; 6(4): 1045–1053.
58.
UrsoE., SerpentiniS., PucciarelliS.. Complications, functional outcome and quality of life after intensive preoperative chemoradiotherapy for rectal cancer.Eur J Surg Oncol.2006; 32(10): 1201–1208.
59.
NessR.M., HolmesA., KleinR.. Outcome states of colorectal cancer: identification and description using patient focus groups.Am J Gas-troenterol.1998; 93(9): 1491–1497.
60.
HolzerB., GyasiA., SchiesselR.. Patients’ expectations of colorectal surgery for cancer.Colorectal Dis.2006; 8(3): 186–191.
61.
MilesC.L., CandyB., JonesL.. Interventions for sexual dysfunction following treatments for cancer.Cochrane Database Syst Rev.2007; (4): CD005540.
62.
LindseyI., GeorgeB., KettlewellM.. Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease.Dis Colon Rectum.2002; 45(6): 727–732.
63.
SterkP., ShekarrizB., GünterS.. Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision: prospective study on 52 patients.Int J Colorectal Dis.2005; 20(5): 423–427.
64.
SchoverL.R., JenkinsR., SuiD.. Randomized trial of peer counseling on reproductive health in African American breast cancer survivors.J Clin Oncol.2006; 24(10): 1620–1626.
65.
LoprinziC.L., Abu-GhazalehS., SloanJ.A.. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer.J Clin Oncol.1997; 15(3): 969–973.
66.
North American Menopause Society. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.Menopause.2007; 14(3 Pt 1): 355–369; quiz 370-371.
67.
GanzP.A., GreendaleG.A., PetersenL.. Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial.J Natl Cancer Inst.2000; 92(13): 1054–1064.
68.
DentonA.S., MaherE.J.. Interventions for the physical aspects of sexual dysfunction in women following pelvic radiotherapy.Cochrane Database Syst Rev.2003; (1): CD003750.
69.
WhiteI.D., FaithfullS.. Vaginal dilation associated with pelvic radiotherapy: a UK survey of current practice.Int J Gynecol Cancer.2006; 16(3): 1140–1146.
70.
RobinsonJ.W., FarisP.D., ScottC.B.. Psychoeducational group increases vaginal dilation for younger women and reduces sexual fears for women of all ages with gynecological carcinoma treated with radiotherapy.Int J Radiat Oncol Biol Phys.1999; 44(3): 497–506.
71.
JeffriesS.A., RobinsonJ.W., CraigheadP.S.. An effective group psychoeducational intervention for improving compliance with vaginal dilation: a randomized controlled trial.Int J Radiat Oncol Biol Phys.2006; 65(2): 404–411.
72.
GanzP.A., GreendaleG.A.. Female sexual desire: beyond testosterone.J Natl Cancer Inst.2007; 99(9): 659–661.
73.
SchoverL.R.. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?Fertil Steril.2008; 90(1): 129–140.
74.
NorthouseL.L., MoodD., TemplinT.. Couples’ patterns of adjustment to colon cancer.Soc Sci Med.2000; 50(2): 271–284.
